Vass Tamás, Bán Kinga, Bennemann Stephan, Balázs Ákos, Szijártó Attila
1 Semmelweis Egyetem, Általános Orvostudományi Kar, Sebészeti, Transzplantációs és Gasztroenterológiai Klinika Budapest, Üllői út 78., 1082 Magyarország.
Orv Hetil. 2024 Feb 11;165(6):203-210. doi: 10.1556/650.2024.32983.
Tumors of the upper gastrointestinal tract have a high mortality. Due to technical advances in recent decades, the survival of patients has improved significantly, but the average 5-year survival rate for neither stomach nor esophageal tumors does not exceed 35%. In countries that have introduced the screening program, patients are often detected at an early stage, when endoscopic care is also possible. With the development of oncology, the multimodal approach in tumor therapy became the standard, thereby opening a way to treat more and more advanced patients for curative purposes. The introduction of minimally invasive techniques, along with adequate oncological radicality, reduced the surgical load and improved postoperative recovery. In recent years, an increasing emphasis has been placed on the complex preparation of patients, so the morbidity indicators associated with surgery have improved further. Here we summarize the changes in the care of tumors of the upper digestive tract. Orv Hetil. 2024; 165(6): 203–210.
上消化道肿瘤的死亡率很高。由于近几十年来的技术进步，患者的生存率有了显著提高，但胃癌和食管癌的平均5年生存率均不超过35%。在推行筛查计划的国家，患者常在早期被发现，此时也可行内镜治疗。随着肿瘤学的发展，肿瘤治疗的多模式方法成为标准，从而为越来越多的晚期患者提供了治愈性治疗的途径。微创技术的引入，在保证足够肿瘤根治性的同时，减轻了手术负担，改善了术后恢复。近年来，越来越重视患者的综合准备，因此与手术相关的发病率指标进一步改善。在此，我们总结上消化道肿瘤治疗的变化。《匈牙利医学周报》。2024年；165(6):203–210。
